Heart attack patients: can a common gout pill improve bypass recovery?
NCT ID NCT05726019
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tested whether the anti-inflammatory drug colchicine can reduce complications like irregular heartbeat, heart sac inflammation, and heart damage after coronary artery bypass surgery. 100 patients who had a recent heart attack and needed bypass surgery were randomly assigned to receive colchicine or a placebo for 30 days after surgery. The goal was to see if colchicine could improve recovery and prevent common post-surgery problems.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ACUTE CORONARY SYNDROME are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Heart Institute - University of São Paulo
São Paulo, São Paulo, 05403000, Brazil
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Software-Guided heart procedures: a new standard for coronary care?
- Heart patients may stay active longer with coach calls and group support
- Sitting less could be a lifeline for frail hearts – a new trial tests a simple program
- Can balloon timing make or break heart artery success?
- Ultrasound 'Memory' imaging may reveal hidden heart ischemia
- Can we predict which heart aneurysms will grow?